正川股份股价下跌2.71% 半年报显示海外市场拓展迅速

Core Viewpoint - Zhengchuan Co., Ltd. experienced a stock price decline of 2.71%, closing at 22.24 yuan, with a trading volume of 42,569 hands and a transaction amount of 0.96 billion yuan [1] Company Overview - Zhengchuan Co., Ltd. specializes in the research, production, and sales of pharmaceutical glass tubes and other medical packaging materials, with a product line that includes pre-filled syringes, cartridge bottles, and non-sterile syringes, covering specifications from 0.5ML to 10ML [1] - The company operates in the medical device sector and is registered in Chongqing [1] Financial Performance - In the first half of 2025, the company reported a revenue of 324 million yuan and a net profit attributable to shareholders of 14.0883 million yuan [1] - The net cash flow from operating activities reached 59.3613 million yuan, reflecting a year-on-year growth of 89.31% [1] Market Expansion - Zhengchuan Co., Ltd. has achieved sales in nearly 20 countries, including Europe, South America, and Southeast Asia, and plans to establish a wholly-owned subsidiary in Hong Kong to expand its international market presence [1] - The company’s emerging business segment showed significant growth in both production and sales compared to the same period last year [1] Capital Flow - On August 22, the net outflow of main funds was 6.5659 million yuan, accounting for 0.2% of the circulating market value [1] - Over the past five days, the net outflow of main funds totaled 6.3941 million yuan, representing 0.19% of the circulating market value [1]